Cost-effectiveness of cannabinoids for pediatric drug-resistant epilepsy: protocol for a systematic review of economic evaluations

Cost-effectiveness of cannabinoids for pediatric drug-resistant epilepsy: protocol for a systematic review of economic evaluations

Abstract Background Drug-resistant epilepsy negatively impacts the quality of life and is associated with increased morbidity and mortality and high costs to the healthcare system. Cannabis-based treatments may be effective in reducing seizures in this population, but whether they are cost-effective...

Full description

Bibliographic Details
Main Authors: Jesse Elliott, Bláthnaid McCoy, Tammy Clifford, Beth K. Potter, Becky Skidmore, George A. Wells, Doug Coyle
Format: Article
Language:English
Published: BMC 2019-03-01
Series:Systematic Reviews
Subjects:
Cannabis
Cannabidiol
Cost-effectiveness
Pediatric drug-resistant epilepsy
Resource use
Costs
Online Access:http://link.springer.com/article/10.1186/s13643-019-0990-z

Internet

http://link.springer.com/article/10.1186/s13643-019-0990-z

Similar Items